Rights and permissions
About this article
Cite this article
Modestly effective HIV vax could be cost effective in the US. Pharmacoecon. Outcomes News 627, 1 (2011). https://doi.org/10.2165/00151234-201106270-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106270-00001